148 related articles for article (PubMed ID: 38170044)
1. Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer.
Poinot H; Dupuychaffray E; Arnoux G; Alvarez M; Tachet J; Ezzar O; Moore J; Bejuy O; Olesti E; Visconti G; González-Ruiz V; Rudaz S; Tille JC; Voegel CD; Nowak-Sliwinska P; Bourquin C; Pommier A
Oncoimmunology; 2024; 13(1):2286820. PubMed ID: 38170044
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma.
Martins Nascentes Melo L; Herrera-Rios D; Hinze D; Löffek S; Oezel I; Turiello R; Klein J; Leonardelli S; Westedt IV; Al-Matary Y; Egea-Rodriguez S; Brenzel A; Bau M; Sucker A; Hadaschik E; Wirsdörfer F; Hanenberg H; Uhlenbrock N; Rauh D; Poźniak J; Rambow F; Marine JC; Effern M; Glodde N; Schadendorf D; Jablonska J; Hölzel M; Helfrich I
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37028818
[TBL] [Abstract][Full Text] [Related]
3. Tumors produce glucocorticoids by metabolite recycling, not synthesis, and activate Tregs to promote growth.
Taves MD; Otsuka S; Taylor MA; Donahue KM; Meyer TJ; Cam MC; Ashwell JD
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37471141
[TBL] [Abstract][Full Text] [Related]
4. G6PC1 and G6PC2 influence G6P flux but not HSD11B1 activity.
Hawes EM; Boortz KA; Oeser JK; O'Rourke ML; O'Brien RM
J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37855366
[TBL] [Abstract][Full Text] [Related]
5. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry.
Han D; Yu Z; Zhang H; Liu H; Wang B; Qian D
Bioengineered; 2021 Dec; 12(2):10891-10904. PubMed ID: 34845968
[TBL] [Abstract][Full Text] [Related]
6. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a role of sterol 27-hydroxylase in glucocorticoid metabolism in vivo.
Vögeli I; Jung HH; Dick B; Erickson SK; Escher R; Funder JW; Frey FJ; Escher G
J Endocrinol; 2013 Nov; 219(2):119-29. PubMed ID: 24096962
[TBL] [Abstract][Full Text] [Related]
8. 11-beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) gene expression in muscle is linked to reduced skeletal muscle index in sarcopenic patients.
Schluessel S; Zhang W; Nowotny H; Bidlingmaier M; Hintze S; Kunz S; Martini S; Mehaffey S; Meinke P; Neuerburg C; Schmidmaier R; Schoser B; Reisch N; Drey M
Aging Clin Exp Res; 2023 Dec; 35(12):3073-3083. PubMed ID: 37943405
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome in anti-neutrophil cytoplasmic antibody-associated vasculitis and gene variants of 11β-hydroxysteroid dehydrogenase type 1 and the glucocorticoid receptor.
Hessels AC; Tuin J; Sanders JSF; Huitema MG; van Rossum EFC; Koper JW; van Beek AP; Stegeman CA; Rutgers A
Rheumatology (Oxford); 2019 Mar; 58(3):447-454. PubMed ID: 30445609
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies.
Adachi Y; Kamiyama H; Ichikawa K; Fukushima S; Ozawa Y; Yamaguchi S; Goda S; Kimura T; Kodama K; Matsuki M; Miyano SW; Yokoi A; Kato Y; Funahashi Y
Cancer Res; 2022 Jan; 82(2):292-306. PubMed ID: 34753772
[TBL] [Abstract][Full Text] [Related]
12. Analysis of alternative promoter usage in expression of HSD11B1 including the development of a transcript-specific quantitative real-time PCR method.
Staab CA; Stegk JP; Haenisch S; Neiss E; Köbsch K; Ebert B; Cascorbi I; Maser E
Chem Biol Interact; 2011 May; 191(1-3):104-12. PubMed ID: 21215738
[TBL] [Abstract][Full Text] [Related]
13. Pro-inflammatory cytokine induction of 11β-hydroxysteroid dehydrogenase type 1 in A549 cells requires phosphorylation of C/EBPβ at Thr235.
Esteves CL; Verma M; Róg-Zielińska E; Kelly V; Sai S; Breton A; Donadeu FX; Seckl JR; Chapman KE
PLoS One; 2013; 8(9):e75874. PubMed ID: 24086653
[TBL] [Abstract][Full Text] [Related]
14. Local glucocorticoid synthesis regulates house dust mite-induced airway hypersensitivity in mice.
Merk VM; Phan TS; Wiedmann A; Hardy RS; Lavery GG; Brunner T
Front Immunol; 2023; 14():1252874. PubMed ID: 37936704
[TBL] [Abstract][Full Text] [Related]
15. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
16. Anti-PD-L1 treatment enhances antitumor effect of everolimus in a mouse model of renal cell carcinoma.
Hirayama Y; Gi M; Yamano S; Tachibana H; Okuno T; Tamada S; Nakatani T; Wanibuchi H
Cancer Sci; 2016 Dec; 107(12):1736-1744. PubMed ID: 27712020
[TBL] [Abstract][Full Text] [Related]
17. Attenuated Activation of Homeostatic Glucocorticoid in Keratinocytes Induces Alloknesis via Aberrant Artemin Production.
Matsumoto A; Murota H; Terao M; Katayama I
J Invest Dermatol; 2018 Jul; 138(7):1491-1500. PubMed ID: 29474943
[TBL] [Abstract][Full Text] [Related]
18. Expression of Receptor Tyrosine Kinases on Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes in Patients with Renal Cell Carcinoma and Healthy Donors.
Tsimafeyeu I; Volkova M; Olshanskaia A; Raskin G; Aschuba S; Khochenkova Y; Bondarenko A; Khochenkov D
Oncology; 2020; 98(4):252-258. PubMed ID: 32053815
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for the species difference between mouse and pig oocytes in their sensitivity to glucorticoids.
Gong S; Sun GY; Zhang M; Yuan HJ; Zhu S; Jiao GZ; Luo MJ; Tan JH
Biol Reprod; 2017 May; 96(5):1019-1030. PubMed ID: 28419184
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab.
Lyu C; Stadlbauer B; Wang L; Buchner A; Pohla H
Front Immunol; 2023; 14():1186388. PubMed ID: 37622107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
